Markets:

Overview

News

Currencies

International

Treasuries

Cytosorbents Corporation - Common Stock (NQ:CTSO)

0.6491 -0.0109 (-1.65%)

Streaming Delayed Price Updated: 1:45 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cytosorbents Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >

Top movers in Tuesday's pre-market session ↗

December 23, 2025

As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Cytosorbents Corp (NASDAQ:CTSO) Posts Mixed Q3 2025 Results Amidst Stock Volatility ↗

November 13, 2025

Cytosorbents Q3 2025 earnings show a mixed quarter, beating EPS estimates but missing on revenue. The stock saw volatility despite a strengthened balance sheet.

Via Chartmill

Cytosorbents (CTSO) Q3 2025 Earnings Transcript ↗

November 13, 2025

Cytosorbents (CTSO) Q3 2025 Earnings Transcript

Via The Motley Fool

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings) ↗

September 16, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

CytoSorbents's Earnings: A Preview ↗

May 13, 2025

Via Benzinga

Insights into CytoSorbents's Upcoming Earnings ↗

March 28, 2025

Via Benzinga

Expert Outlook: CytoSorbents Through The Eyes Of 7 Analysts ↗

January 13, 2025

Via Benzinga

Wednesday's pre-market session: top gainers and losers ↗

August 20, 2025

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 20, 2025

Via Benzinga

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

August 20, 2025

Via Benzinga

Demystifying CytoSorbents: Insights From 5 Analyst Reviews ↗

August 08, 2025

Via Benzinga

CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss ↗

August 07, 2025

CytoSorbents (CTSO) reported Q2 2025 results with revenue of $9.62M, beating estimates, and a narrower EPS loss of -$0.05. Shares rose 4.32% post-earnings amid steady demand for CytoSorb.

Via Chartmill

A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts ↗

July 21, 2025

Via Benzinga

Top movers in Wednesday's session ↗

July 02, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 02, 2025

Via Benzinga

These stocks are moving in today's session ↗

July 02, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Gapping stocks in Wednesday's session ↗

July 02, 2025

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings) ↗

June 25, 2025

Via Benzinga

Demystifying CytoSorbents: Insights From 4 Analyst Reviews ↗

May 02, 2025

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 02, 2025

Via Benzinga

The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts ↗

April 01, 2025

Via Benzinga

Earnings Scheduled For March 31, 2025 ↗

March 31, 2025

Via Benzinga

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

March 04, 2025

The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb™-ATR marketing...

From CytoSorbents

Via GlobeNewswire

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

February 26, 2025

From CytoSorbents

Via GlobeNewswire

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

February 25, 2025

1,417,208 Series A Right Warrants Exercised at $1.13 Per Share, Providing $1.6 Million in Aggregate Gross Proceeds

From CytoSorbents

Via GlobeNewswire

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

January 13, 2025

From CytoSorbents

Via GlobeNewswire

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

January 06, 2025

From CytoSorbents

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.